Regional Specialist, Revenue Growth Management LATAM at Abbott

Hollywood, Florida, United States

Apply Now

$85,300 – $170,700Compensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor’s degree
Minimum of 7 years in Revenue Growth Management, Strategic Pricing, Profitability/Margin Improvement, or Commercial Finance (preferably in the pharmaceutical or consumer goods sector)
Strong knowledge of pricing structures, profitability analysis, and GTN management
Advanced Excel skills and proficiency in data visualization tools (Power BI, Tableau)
Financial modeling and analytical skills
Ability to influence and work in multicultural matrix environments
Advanced English (spoken and written)
MBA preferred

Responsibilities

Lead the strategic pricing and Gross-to-Net (GTN) practice across the LATAM region to maximize sustainable profitability and drive business growth
Play a key part in strategic commercial decision-making, working closely with Finance, Marketing, Sales, and Commercial teams
Establish governance frameworks and oversee the RGM function in key regional markets
Identify pricing and GTN opportunities to enhance both revenue growth and net profitability
Ensure effective tracking of implementation and impact

Skills

Revenue Growth Management

Strategic Pricing

GTN Management

Profitability Analysis

Financial Modeling

Advanced Excel

Power BI

Tableau

Pricing Structures

Abbott

Healthcare solutions in diagnostics and devices

About Abbott

Abbott Laboratories focuses on improving health through various medical technologies and health solutions. The company operates in areas such as cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's products include advanced medical devices and diagnostic tests that help healthcare professionals and patients manage health conditions effectively. For example, their cardiovascular technologies assist in heart health management, while diabetes care products enable accurate glucose monitoring without painful fingersticks. Unlike many competitors, Abbott emphasizes accessibility and affordability in its offerings, aiming to make life-changing technologies available to a broader audience. The company's goal is to positively impact global health and well-being, supported by a commitment to sustainability and a 2030 Sustainability Plan.

Lake Bluff, IllinoisHeadquarters

1888Year Founded

IPOCompany Stage

HealthcareIndustries

10,001+Employees

Risks

Departure of key leader Dr. Adamson may affect Abbott's Heart Failure division.

Integration challenges with Medtronic could impact glucose monitor-insulin pump rollout.

Thermo Fisher's microfluidics expansion may increase competition for Abbott.

Differentiation

Abbott integrates continuous glucose monitoring with automated insulin delivery systems.

Abbott's microfluidic devices streamline diagnostic processes efficiently.

Abbott's neuromodulation products target specific nervous system areas for chronic pain relief.

Upsides

Microfluidic technology offers cost-effective solutions in diagnostics.

Strategic partnerships like Abbott-Medtronic enhance product offerings and market reach.

Significant investments indicate strong market confidence in Abbott's healthcare solutions.

Land your dream remote job 3x faster with AI

Try Jobo Free